Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.7K
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

2.1K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
2.1K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

13.4K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
13.4K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

3.7K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel mouse model of chronic Pseudomonas aeruginosa infection inducing bronchiectasis-like phenotype.

Animal models and experimental medicine·2026
Same author

The natural isoflavone puerarin mitigates cerebral ischemia-reperfusion injury by directly targeting CaMKⅡδ to block DLG4-Ser654 phosphorylation.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same author

[Retracted] Combined application of Embelin and tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase-induced apoptosis.

Oncology letters·2026
Same author

Molecular Mechanisms and Metabolic Responses in the Biological Antagonism Between <i>Trichoderma harzianum</i> and <i>Fusarium oxysporum</i>.

Microorganisms·2026
Same author

KIBRA impairs DNA damage repair and suppresses osteosarcoma progression by inhibiting the Wnt/β-catenin signaling activity.

Cell cycle (Georgetown, Tex.)·2026
Same author

Fyn promotes NLRP3 inflammasome activation in microglia and exacerbates early brain injury following subarachnoid hemorrhage.

Free radical biology & medicine·2026
Same journal

A Multi-Modal Framework for Phage-Host Interaction Prediction Using Multi-View Contrastive Learning.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

Decoding Gene-Disease Associations with Computational Methods: A Survey.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

A Competitive Coevolution-based Cancer Driver Pathway Identification Algorithm for Maximizing Coverage, Mutual Exclusivity, and Subnet Importance.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

Prediction of GO Terms Based on Partitioning PPI Networks into Highly Connected Components.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

Modeling and Tracking of Heterogeneous Cell Populations via Open Multi-Agent Systems.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

Parameter Efficient Deep Learning Models for Multi-Target Binding Affinity and hERG Cardiotoxicity Prediction.

IEEE transactions on computational biology and bioinformatics·2026
See all related articles

Related Experiment Video

Updated: Sep 11, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

527

Multi-Objective Structure-Based Drug Design Using Causal Discovery.

Jingyuan Zhou, Dengwei Zhao, Hao Qian

    IEEE Transactions on Computational Biology and Bioinformatics
    |August 14, 2025
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces a novel multi-objective structure-based drug design (SBDD) algorithm using diffusion models. It optimizes multiple drug properties simultaneously, overcoming limitations of prior methods for enhanced drug candidate generation.

    More Related Videos

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
    05:10

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

    Published on: December 11, 2016

    9.7K
    Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
    22:10

    Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit

    Published on: June 28, 2013

    13.4K

    Related Experiment Videos

    Last Updated: Sep 11, 2025

    Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
    08:49

    Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

    Published on: June 20, 2025

    527
    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
    05:10

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

    Published on: December 11, 2016

    9.7K
    Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
    22:10

    Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit

    Published on: June 28, 2013

    13.4K

    Area of Science:

    • Computational chemistry
    • Drug discovery
    • Artificial intelligence in medicine

    Background:

    • Structure-based drug design (SBDD) is crucial for identifying drug candidates.
    • Deep generative models are increasingly vital in SBDD.
    • Current SBDD methods often fail to address multi-objective optimization due to property interdependencies.

    Purpose of the Study:

    • To develop a multi-objective SBDD algorithm capable of optimizing multiple drug properties concurrently.
    • To address the limitations of existing methods that neglect property relationships or focus on single objectives.
    • To generate drug candidates with improved overall potential by considering complex property interactions.

    Main Methods:

    • A novel multi-objective SBDD algorithm based on diffusion models.
    • Parallel training of multiple expert networks for property prediction and gradient transmission.
    • Construction of a causal graph using causal discovery algorithms to model property relationships.
    • Decomposition of joint property distributions guided by the causal graph during molecule generation.

    Main Results:

    • The proposed algorithm effectively optimizes multiple objectives, including binding affinity and other crucial drug properties.
    • It successfully generates molecules with higher drug potential compared to baseline models.
    • Demonstrated ability to handle conflicting property relationships during the generative process.

    Conclusions:

    • The developed diffusion model-based SBDD algorithm offers a significant advancement in multi-objective drug design.
    • Considering causal relationships among properties is key to generating superior drug candidates.
    • This approach enhances the feasibility of designing molecules that meet diverse and potentially conflicting criteria.